180 likes | 313 Views
Measuring the Quality of Long-Term Care in England. Juliette Malley Personal Social Services Research Unit LSE Health and Social Care London School of Economics. Structure. Key players in England Main features of quality assurance programme Quality measures Evidence on quality
E N D
Measuring the Quality of Long-Term Care in England Juliette Malley Personal Social Services Research Unit LSE Health and Social Care London School of Economics
Structure • Key players in England • Main features of quality assurance programme • Quality measures • Evidence on quality • Limitations of measures
Key players – focus of inquiry • NHS not focus • LTC is social care not health care • LAs responsible for social care • Dual focus on Local Authorities (LAs) + care providers • Quasi-market – LAs commissioners • Private market – social care is means tested
Key players – Measurement • Policy-makers • Department of Health (DH) • Communities and Local Government department (CLG) • Set policy, QA framework, objectives & what data should be collected • Regulator • Care Quality Commission (CQC) • Drive quality improvement • Others – limited role • Academics • LAs for contracting purposes
Approach to quality assurance (QA) • National system supported by legislation • Comprehensive • ‘Business approach’ • Inspections integrated into performance assessment • Measures support QA i.e. PIs… • …& emerge from QA process i.e. ratings
Quality measures • What is the object of measurement? • How is quality conceptualised? • How are the measures specified and by whom? • How are the measures used?
What is the object of measurement? • LAs • Role as commissioners • Role as market-shapers • Care providers • Provision by residential providers • Provision by home care providers
How is quality conceptualised? • ‘Outcomes’ for service users • Improved health & emotional well-being • Improved quality of life • Making a positive contribution • Increased choice and control • Freedom from discrimination or harassment • Economic well-being • Maintaining personal dignity and respect • NOT clinical outcomes e.g. pressure ulcers • Previous focus on ‘structure’ and ‘process’
How are the measures specified and by whom? (1) • Performance indicators (PIs) • For LAs only • Quantitative measures • From surveys and data systems • Various types: activity, costs, process & structural quality • No outcomes but new PIs under development • E.g. % of items of equipment and adaptations delivered within 7 working days
How are the measures specified and by whom? (2) • Composite measures • For LAs and providers • Rating awarded on scale of one to four • Judgement made by CQC inspectors • Annual for LAs • After key inspection for providers, frequency depends on judgement • Based on mix of qualitative and quantitative data • Inspections, management, self-assessment, PIs • Aim to address partial picture presented by PIs
How are the measures used? • PIs • Support planning process locally • Accountability • Used by CQC in performance assessment • Targets, with financial reward • Composite measures • Determine relationship with regulator e.g. frequency of inspections, degree of intervention • Public accountability • Correct information asymmetries – efficient markets
Limitations of measures (1) • Composite measures • Sensitivity questions • Averaging across different domains • Reliability/accuracy questions • Consistency of inspector judgements • Sensitive to rules applied for scoring • Policy changes means data & rules used changed over time • Not updated annually for good/excellent providers – rely on stability and self-assessment • If measures are not sensitive/reliable will/should they be used for commissioning?
Limitations of measures (2) • PIs • Changes in definitions • Policy changes – new PIs & old dropped • Captures aspects of process to date, not outcomes
Limitations of measures (3) • Measures used to change behaviour • Improvements could be result of pressure applied to improve • e.g. PIs are targets – distribution condenses • e.g. increased monitoring & intervention for poor performers – distribution condenses • e.g. provider ratings for good/excellent not updated annually – tend towards improvement • If measures do not have variability are they useful? • Independent data would be valuable
Conclusions • Great start… • National & comprehensive system for QA • National quality measures • Combine ‘soft’ & ‘hard’ data • But some questions over accuracy & sensitivity… • Some questions over whether these measures are useful for commissioning, particularly in long-run • Independent assessment of validity & reliability of national measures would be valuable